Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $26.59 USD
Change Today +0.25 / 0.95%
Volume 817.5K
As of 3:08 PM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Glenn P. Sblendorio Mba

President, Chief Financial Officer, Treasurer and Director, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 52 board members in 5 different organizations across 7 different industries.

See Board Relationships
58$2,735,030
As of Fiscal Year 2013

Background*

Mr. Glenn P. Sblendorio has been the President at The Medicines Company since February 21, 2012 and has been its Chief Financial Officer since March 17, 2006 and its Treasurer. Mr. Sblendorio serves as Principal Accounting Officer of The Medicines Company and served as its Executive Vice President from March 17, 2006 to February 2012. Mr. Sblendorio served as a Treasurer of Targanta Therapeutics Corp., a subsidiary of Medicines Co. since February 25, 2009. He joined ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

Chairman
2006-Present
Director and Chairman of Audit Committee
2009-N/A
Former Treasurer, Director, Chief Financial Officer of The Medicines Company and Executive Vice President of The Medicines Company
2011-Present
President, Chief Financial Officer, Treasurer and Director
2013-Present
Director and Chairman of Audit Committee
2014-Present
Director and Member of Audit Committee

Education*

BBA
Pace University
MBA
Fairleigh Dickinson University

Other Affiliations*

Annual Compensation*

Salary$569,296
Total Annual Compensation$569,296

Stock Options*

Restricted Stock Awards$1,175,994
All Other Compensation$3,214
Exercised Options225,000
Exercised Options Value$2,708,858
Exercisable Options172,107
Exercisable Options Value$3,130,106
Unexercisable Options94,311
Unexercisable Options Value$1,419,284
Total Value of Options$7,258,248
Total Number of Options491,418

Total Compensation*

Total Annual Cash Compensation$1,057,266
Total Short Term Compensation$569,296
Other Long Term Compensation$1,179,208
Total Calculated Compensation$2,735,030
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $26.59 USD +0.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
$827.8K
Pamela Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Joze Colaric President of Management Board and Chief Executive Officer
KrKa dd Novo Mesto
€769.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.